Eledon Pharmaceuticals, Inc. Debt Securities, Available-for-sale, Amortized Cost
Eledon Pharmaceuticals, Inc. (ELDN) had Debt Securities, Available-for-sale, Amortized Cost of $82.07 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2026-08-13
- 2026-06-30: Debt Securities, Available-for-sale, Amortized Cost $82.07M.
- 2026-03-31: Debt Securities, Available-for-sale, Amortized Cost $105.01M.
- 2025-12-31: Debt Securities, Available-for-sale, Amortized Cost $110.51M.
- 2025-09-30: Debt Securities, Available-for-sale, Amortized Cost $89.72M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2026-06-30 | $82.07M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $105.01M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $110.51M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $89.72M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $101.88M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $116.40M 10-Q/A · filed 2025-08-14 |
| 2024-12-31 | $119.60M 10-K · filed 2026-03-19 |
| 2024-09-30 | $71.34M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $57.57M 10-Q · filed 2024-08-19 |
| 2024-03-31 | $37.21M 10-Q/A · filed 2024-08-19 |
| 2023-12-31 | $46.49M 10-K/A · filed 2025-08-14 |
| 2023-09-30 | $55.94M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $30.43M 10-Q · filed 2023-08-10 |
| 2016-12-31 | $4.18M 10-Q · filed 2017-05-03 |
| 2016-09-30 | $16.09M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $31.77M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $39.95M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $39.99M 10-K · filed 2017-03-03 |
| 2015-09-30 | $39.93M 10-Q · filed 2015-11-10 |
| 2015-06-30 | $24.11M 10-Q · filed 2015-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |